Table 1 Study 1: patient characteristics
Cancer patients (N = 450) | |
|---|---|
Age in years m (SD); med (IQR); min–max | 62.2 (12.3), 63.0 (54.0–71.0), 21–89 |
Sex no. (%) | |
Female | 209 (46.4) |
Male | 241 (53.6) |
Education no. (%) | |
Less than some post compulsory education | 176 (39.1) |
At least some post compulsory (~ upper secondary) education | 272 (60.4) |
Missing | 2 (0.4) |
Country no. (%) | |
Germany | 393 (87.3) |
Switzerland | 37 (8.2) |
Austria | 20 (4.4) |
Cancera no. (%) | |
Oral cavity and throat (C00–C14) | 32 (7.1) |
Digestive organs (C15–C26) | 93 (20.7) |
Respiratory and chest organs (C30–C39) | 50 (11.1) |
Bones and joint cartilage (C40–C41) | 2 (0.4) |
Malignant melanoma (C43) | 37 (8.2) |
Non-melanoma skin cancer (C44) | 26 (5.8) |
Skin cancer not defined (C43–C44) | 5 (1.1) |
Soft and mesothelial tissue (C45–C49) | 2 (0.4) |
Mammary gland (C50) | 45 (10.0) |
Female sex organs (C51–C58) | 29 (6.4) |
Male sex organs (C60–C63) | 41 (9.1) |
Urinary organs (C64–C68) | 29 (6.4) |
Eye, brain, and central nervous system (C69–C72) | 4 (0.9) |
Endocrine glands (C73–C75) | 3 (0.7) |
Cancer of unknown primary syndrome (C76–C80) | 9 (2.0) |
Blood and lymph gland cancer (C81–C96) | 36 (8.0) |
Pituitary adenoma (D35) | 1 (0.2) |
More than one diagnosis | 5 (1.1) |
Unknown | 1 (0.2) |
Time from initial cancer diagnosis to initial assessmentb in months m (SD); med (IQR); min–max | 25.9 (52.6), 4.6 (1.6–21.1), 0–366 |
Cancer stage no. (%) | |
Local | 176 (39.1) |
Locally advanced | 123 (27.3) |
Metastatic | 133 (29.6) |
Missing/not applicablec | 18 (4.0) |
Hospitalization no. (%) | |
Inpatient | 291 (64.7) |
Outpatient | 159 (35.3) |
Treatment status no. (%) | |
Pretreatment | 13 (2.9) |
In treatment | 387 (86.0) |
Aftercare | 50 (11.1) |
Currently on treatment no. (%) | |
No | 63 (14.0) |
Yes | 387 (86.0) |
Systemic treatment | 152 (33.8) |
Local treatment | 168 (37.3) |
Systemic and local treatment | 67 (14.9) |
Previous treatment no. (%) | |
Unknown | 111 (24.7) |
No | 169 (37.7) |
Yes | 170 (37.8) |
Systemic treatment | 23 (5.1) |
Local treatment | 99 (22.0) |
Systemic and local treatment | 48 (10.7) |
Comorbidity no. (%) | |
No | 97 (21.6) |
Yes at least one additional disease | 353 (78.4) |
Multiple answers possible (sum > 100%) | |
Injuries | 43 (9.6) |
Diseases of the musculoskeletal system | 103 (22.9) |
Cardiovascular diseases | 192 (42.7) |
Respiratory diseases | 79 (17.6) |
Mental impairment | 47 (10.4) |
Neurological and sensory diseases | 69 (15.3) |
Diseases of the digestive system | 84 (18.7) |
Diseases of the urogenital tract | 73 (16.2) |
Skin diseases | 50 (11.1) |
Metabolic and hormonal disorders | 129 (28.7) |
Blood disorder | 17 (3.8) |
Congenital diseases | 11 (2.4) |
Other | 6 (1.3) |